Skip to main content
S 859 108th Congress Senate Health AIDS (Disease) Clinical trials Congress Congressional reporting requirements Department of Health and Human Services Department of State Drugs Economics and Public Finance Executive reorganization Federal aid to research Government Operations and Politics Human immunodeficiency viruses International Affairs International cooperation in science Medical research Pharmaceutical research Preventive medicine Product development Psychology

Microbicide Development Act of 2003

Introduced: April 10, 2003 See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 108th Congress ended
It never became law before the 108th Congress (2003–2004) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 10, 2003
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S5183-5185)
Apr 10, 2003
Sponsor introductory remarks on measure. (CR S5182-5183)
Apr 10, 2003
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service
Microbicide Development Act of 2003 - Amends the Public Health Service Act to require the Director of the Office of AIDS Research to expedite the development of a Federal strategic plan for the conduct and support of microbicide research.

Requires the Director of such office to expand, intensify, and coordinate the activities of all appropriate institutes and components of the National Institutes of Health with respect to research on the development of microbicides to prevent the transmission of HIV and other sexually transmitted diseases.

Requires the Director of the National Institute of Allergy and Infectious Diseases to establish within the Vaccine and Prevention Research Program of the Division of AIDS in the Institute, a branch charged with carrying out microbicide research and development.

Requires the Director of the Centers for Disease Control and Prevention to fully implement the Centers' five-year topical microbicide agenda to support microbicide research and development.

Directs the Office of HIV/AIDS of the Agency for International Development, in conjunction with other offices within AID, to fully implement AID's microbicide agenda to support the development of microbicides, and facilitate wide-scale introduction once microbicide products are available.

What's happening now April 10, 2003

Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S5183-5185)

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 3
All 3 Democratic 3
D
Cantwell, Maria
Washington · Apr 10, 2003
 D
Durbin, Richard J.
Illinois · Apr 10, 2003
 D
Murray, Patty
Washington · Apr 10, 2003
Cite this page click to expand
APA
U.S. Congress. (2026). S. 859: Microbicide Development Act of 2003. 108th Congress. Open America. https://openamerica.io/bill/108-S-859/
MLA
"S. 859: Microbicide Development Act of 2003." 108th Congress, 2026, Open America, https://openamerica.io/bill/108-S-859/.
Bluebook (legal)
S. 859, 108th Cong. (2026), https://openamerica.io/bill/108-S-859/.
Markdown link
[S. 859: Microbicide Development Act of 2003](https://openamerica.io/bill/108-S-859/)
Report a problem